BALPHARMA.NSBALPHARMA.NSNSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank86
3Y CAGR+124.6%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+124.6%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
11.3x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 140.11% |
| 2024 | -60.46% |
| 2023 | 17.24% |
| 2022 | 12.36% |
| 2021 | 211.94% |
| 2020 | -26.58% |
| 2019 | -0.13% |
| 2018 | -9.09% |
| 2017 | 160.33% |
| 2016 | -76.61% |